retatrutide weight loss clinical trial results Eli Lilly infiltrates anti-obesity market as Phase III for begins Retatrutide Results After 40: Realistic

Eur J Hosp Pharm

25 In 2005, exenatide was approved by the U.S

CrossRef Paired snRNA-seq and scRNA-seq analysis of MASLD patients to identify early-stage markers for disease progression Suebin Park, Su-Hyeon Lee, Se-eun Han, Beom Kyung Kim, Byungjin Hwang Hepatology Communications .2025;[Epub] CrossRef Sex Hormones and Metabolic Dysfunction-Associated Steatotic Liver Disease Ralf Weiskirchen, Amedeo Lonardo International Journal of Molecular Sciences .2025

1 As the use of these medications increases, this is an opportunity for facilities to review their preadmission screening and medication reconciliation processes